Welcome to our dedicated page for Airsculpt Technologies SEC filings (Ticker: AIRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of premium body contouring procedures. Through these documents, investors can review how the company reports its financial condition, operating results, governance changes and capital markets activity.
AirSculpt’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q contain audited and interim financial statements, management’s discussion and analysis, detailed risk factors and information about its single operating segment focused on direct medical procedure services. These filings also discuss the company’s use of non-GAAP measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income and Adjusted Net Income per Share, along with reconciliations to GAAP metrics.
Current reports on Form 8‑K disclose material events, including quarterly earnings releases, updates to revenue and Adjusted EBITDA guidance, leadership and board changes, executive employment terms, resignations of officers, and capital structure developments. Recent 8‑K filings, for example, describe the appointment of a new Chief Financial Officer, the election of a Non-Executive Chairman of the Board, executive and board departures, and the announcement of quarterly results.
For those monitoring ownership and compensation, proxy materials and, where applicable, insider transaction reports on Form 4 can provide additional insight into equity awards, performance-based restricted stock units and other elements of the company’s equity incentive plans as referenced in its filings.
Stock Titan enhances this filings feed with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand changes in guidance, capital structure, risk disclosures and governance arrangements. Filings are updated in near real time as they are posted to EDGAR, allowing investors, analysts and other stakeholders to follow AirSculpt’s regulatory reporting history and evaluate AIRS stock using primary source information.
Airsculpt Technologies, Inc. amendment reports Parian Ultreia beneficially owns 6,744,000 shares (9.6%). The Schedule 13G/A (Amendment No. 2) lists Parian Ultreia as a Delaware filer holding 6,744,000 shares with sole voting and dispositive power. The filing is signed by Portfolio Manager Zachary Miller and dated 04/21/2026.
Airsculpt Technologies, Inc. insider Jorey Chernett reported an open-market purchase of 40,000 shares of Common Stock at a weighted average price of $2.54 per share. After this transaction, Chernett directly owns 7,053,761 Common Stock shares. The filing notes the shares were bought in multiple trades between $2.52 and $2.56.
The filing also reports the expiration of short call option positions on Airsculpt common stock. Call options on 200,000 underlying shares with a $5.00 exercise price and on 200,400 underlying shares with a $4.00 exercise price expired unexercised because the market price was below the exercise prices, and no consideration was received in connection with these expirations.
AirSculpt Technologies, Inc. is holding a virtual annual stockholder meeting on May 12, 2026 at 8:30 AM Eastern Time. Stockholders will vote on electing three Class II directors for three-year terms and ratifying Grant Thornton as independent registered public accounting firm for fiscal 2026.
The board has seven members, six of whom are independent, and is divided into three staggered classes. The proxy describes virtual-only access procedures, voting mechanics for record and beneficial holders, and quorum and vote standards. It also outlines 2025 executive pay, which combines base salary, cash incentives tied to revenue, EBITDA and debt prepayment, and equity awards in the form of restricted stock units and performance-based units tied to relative total shareholder return or stock price performance.
Airsculpt Technologies, Inc. major holder Jorey Chernett reported an open-market purchase of 20,000 shares of Common Stock at a weighted average price of $2.60 per share. After this transaction, he directly holds 7,013,761 shares of Airsculpt common stock.
Jashnani Yogesh reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies, Inc. reported that Chief Executive Officer Yogesh Jashnani received a grant of 238,095 shares of Common Stock in the form of Restricted Stock Units on April 8, 2026 under the company’s 2021 Equity Incentive Plan. These RSUs will vest in three equal annual installments starting on April 8, 2027, contingent on his continued employment. Following this equity award, Jashnani directly holds 696,475 shares of Airsculpt common stock.
Arthur Michael J reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies, Inc. reported that Chief Financial Officer Arthur Michael J received a grant of 68,027 shares of Common Stock as Restricted Stock Units on April 8, 2026 under the 2021 Equity Incentive Plan. The RSUs will vest in three equal annual installments beginning April 8, 2027, subject to his continued employment. Following this award, he directly holds 215,086 shares of common stock.
WADMAN BRENT R reported acquisition or exercise transactions in this Form 4 filing.
Airsculpt Technologies, Inc. reported that its General Counsel, Brent R. Wadman, received an equity award on April 8, 2026. He was granted 55,272 Restricted Stock Units (RSUs) under the company’s 2021 Equity Incentive Plan, with no cash paid per share.
The RSUs will vest in three equal annual installments beginning on April 8, 2027, as long as he remains employed by the company. Following this grant, he reports ownership of 55,272 shares of common stock directly tied to this award.
Airsculpt Technologies, Inc. ten percent owner Jorey Chernett bought 60,000 shares of common stock in an open-market purchase. The weighted average price was $2.93 per share, with individual trades between $2.91 and $2.94. Following this transaction, Chernett directly holds 6,993,761 shares of Airsculpt common stock.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett reported an open-market purchase of 90,000 shares of common stock at a weighted average price of $2.82 per share. Following this transaction, Chernett directly holds 6,933,761 shares of Airsculpt common stock.
The shares were bought in multiple trades at prices ranging from $2.67 to $3.00 per share, with the reported price representing the rounded weighted average across those individual transactions.